This user currently has no profile.
Over 30 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
- Description: Full-time Investor.
- Interests: Bonds, Commodities, Dividend stock ideas & income, ETFs, Gold, Stocks - long
Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no book details. Click edit to add book details.
LATEST STOCKTALK more »
Latest Comments more »
- Agree w both Vince and Ptat... on Gilead Beats And Raises: Thinking Through The F...
- Ernie, you're very welcome,... on Gilead Beats And Raises: Thinking Through The F...
- SpoiledRotten, thanks for a... on Gilead Beats And Raises: Thinking Through The F...
- Ptatty, the Feds both in th... on Gilead Beats And Raises: Thinking Through The F...
- Again, you're welcome, gris... on The Importance Of Newly-Released Data For Gilea...
Latest comments on DoctoRx's Articles
Latest Articles on Healthcare
LATEST ARTICLES & INSTAPOSTS more »
- Gilead Beats And Raises: Thinking Through The Future Of Its Business And Its Stock Price
- The Importance Of Newly-Released Data For Gilead's HIV Drug Patent Cliff
- Biogen Falls Hard: Is It Undervalued Now?
- An Assessment Of Celgene's Deal For Receptos
- An Analysis Of Intercept Pharma, An Innovator In Serious Liver Diseases With Unmet Needs